Clinical characteristics of COVID-19 patients treated in emergency COVID-19 hospitals in Vietnam: Experience from Phutho province, Vietnam

This study aimed to evaluate the clinical characteristics, patient's management approaches, and outcomes of the COVID-19 patients in Phu Tho Province, Vietnam. A retrospective, multicenter study of 2166 COVID-19 patients in 13 hospitals in Phutho Province, Vietnam. The subjects were divided int...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of medical sciences Vol. 21; no. 6; pp. 1072 - 1078
Main Authors Nguyen, Ngoc Huy, Tran, Khanh Minh, Jong, Lee Hoon, Le, Son Thanh Dinh, Nguyen, An Quang, Duong, Duc Minh, Nguyen, To Dang, Nguyen, Lan Ngoc Thi, Dam, Lan Thi Phuong, Nguyen, Tuan Ngoc Minh
Format Journal Article
LanguageEnglish
Published Australia Ivyspring International Publisher 2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This study aimed to evaluate the clinical characteristics, patient's management approaches, and outcomes of the COVID-19 patients in Phu Tho Province, Vietnam. A retrospective, multicenter study of 2166 COVID-19 patients in 13 hospitals in Phutho Province, Vietnam. The subjects were divided into 3 groups based on vaccination status: unvaccinated group, 1 dose of vaccine group, 2 dose of vaccine group. The clinical characteristics, management approaches, and outcomes were collected and compared between the 3 groups. The hospitalization rate of the 3 groups decreased from the unvaccinated group, the 1 dose of vaccinated group, to the 2 dose of vaccinated group, 42.61%; 30,24% and 27,15% respectively. The 19-40 years old group had the highest hospitalization rate (38,1%) together with the group that had not accepted the full COVID 19 vaccination dose (57,64%). The 2 dose of vaccinated group had the lowest percentages of high temperature, cough, dyspnea, chest pain and sore throat. The unvaccinated group had the highest heart rate, respiratory rate and SpO2 compared to the two other groups. The percentage needing Immunomodulation and Anticoagulant Therapy was highest (6.8% and 1.4 % respectively) in the unvaccinated group. The percentage receiving Antiviral Therapy was highest (42,5%) in those who had received the 2 dose of vaccine. COVID-19 vaccination improved the symptoms of the patients and should be accepted in all ages.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Competing Interests: The authors have declared that no competing interest exists.
ISSN:1449-1907
1449-1907
DOI:10.7150/ijms.94461